Late Cardiac Effects of Therapy for Hodgkin Lymphoma

Matasar M and Gupta D

Department of Medicine, Memorial Sloan Kettering Cancer Center, USA
Department of Medicine, Weill Cornell Medical College, USA

^*Correspondance to: Matthew Matasar 

 PDF  Full Text Review Article | Open Access

Abstract:

Hodgkin lymphoma (HL) is a leading cause of cancer among adolescents, and is often cured with chemotherapy alone or in combination with radiation therapy. Awareness of potential adverse cardiovascular sequelae due to therapy is crucial. Radiation-induced heart disease can affect cardiovascular structures in the radiation field, and risks of cardiovascular damage can be further increased due to exposure to anthracycline chemotherapy. This review provides a broad overview of the etiology, clinical presentation, surveillance and clinical challenges associated with late cardiotoxicity in HL survivors.

Keywords:

Radiation-induced heart disease; Hodgkin lymphoma; Cancer survivors; Cardiotoxicity

Cite the Article:

Matasar M, Gupta D. Late Cardiac Effects of Therapy for Hodgkin Lymphoma. Clin Oncol. 2016; 1: 1042.